Exploring and improving CRISPR technology for gene editing and diagnostics
Discovery and engineering of CRISPR/Cas systems
['FUNDING_OTHER'] · UNIVERSITY OF FLORIDA · NIH-10908290
This study is exploring a special type of CRISPR system found in unique microorganisms to make gene editing better and create new tools for diagnosing diseases, which could help patients get more effective treatments in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-10908290 on ClinicalTrials.gov |
What this research studies
This research focuses on discovering and understanding type V CRISPR/Cas systems found in unique microorganisms. By studying these systems, the researchers aim to enhance the effectiveness of CRISPR technology for gene editing and develop new diagnostic tools for various diseases. The approach involves engineering components of the CRISPR system to improve their performance and applicability in medical settings. Patients may benefit from advancements in gene editing techniques that could lead to more effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic disorders or diseases that could be targeted by advanced gene editing techniques.
Not a fit: Patients with conditions that are not amenable to gene editing or those who do not have genetic components to their diseases may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and effective gene editing therapies and diagnostic tools for a range of diseases.
How similar studies have performed: Other research has shown promise in utilizing CRISPR technology for gene editing, but the exploration of type V systems is relatively novel and less tested.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JAIN, PIYUSH K — UNIVERSITY OF FLORIDA
- Study coordinator: JAIN, PIYUSH K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer Anti-Estrogen Resistance 1 Protein